Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$2.4 million.

  • Journey Medical's Free Cash Flow fell 105.96% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 85.89%. This contributed to the annual value of -$24.1 million for FY2024, which is 10152.92% down from last year.
  • Latest data reveals that Journey Medical reported Free Cash Flow of -$2.4 million as of Q3 2025, which was down 152.97% from -$942,000 recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Free Cash Flow ranged from a high of $18.7 million in Q3 2023 and a low of -$19.1 million during Q1 2022.
  • Over the past 3 years, Journey Medical's median Free Cash Flow value was -$2.4 million (recorded in 2025), while the average stood at -$1.4 million.
  • Per our database at Business Quant, Journey Medical's Free Cash Flow plummeted by 1,504.56% in 2022 and then soared by 357.44% in 2023.
  • Journey Medical's Free Cash Flow (Quarterly) stood at -$3.2 million in 2021, then fell by 19.65% to -$3.8 million in 2022, then plummeted by 330.66% to -$16.5 million in 2023, then skyrocketed by 113.47% to $2.2 million in 2024, then plummeted by 105.96% to -$2.4 million in 2025.
  • Its Free Cash Flow stands at -$2.4 million for Q3 2025, versus -$942,000 for Q2 2025 and -$2.8 million for Q1 2025.